Senators to Address Hemp THC Ban After August Recess

When Congress returns from its August recess, House Republicans face a crucial task of passing stopgap funding legislation. A key issue is the provision to delay the prohibition on most hemp-derived THC products until December 11. Representative Andy Harris (R-Md.), a vocal opponent of the provision, argues that these products resemble unregulated marijuana. He aims to end what he sees as the federal government’s failure to regulate these substances.

Harris chairs the House Agriculture Appropriations Subcommittee and played a significant role with Sen. Mitch McConnell (R-Ky.) in last year’s legislation enforcing the ban. The White House pushed for the delay in the Senate legislation to prioritize resolving issues around the hemp ban. This delay is considered a win by hemp industry groups, allowing them time to advocate for regulation rather than prohibition.

Earlier attempts to remove the delay provision from the Senate’s funding bill failed. A vote on an amendment proposed by Sen. Ted Budd (R-N.C.), which aimed to maintain the original ban, was tabled. The opposition to the delay crossed party lines but was insufficient to overturn the provision. Although GOP senators plan to revisit the ban’s implementation in the near future, White House officials have indicated no further delays will be requested past December 11.

The funding bill’s duration lasts until December 11. The debate continues as lawmakers seek solutions to regulate or ban hemp-derived THC products.

Welcome to The Hill’s Healthcare newsletter. Nathaniel Weixel and Joseph Choi report how Washington impacts your health each week.

Essential Reads: Healthcare Sector Impacts

• The Food and Drug Administration (FDA) approved updated COVID-19 vaccines for high-risk individuals, allowing shipments to pharmacies and physicians’ offices. Pfizer-BioNTech and Moderna received approval for new mRNA vaccine formulations, along with a non-mRNA vaccine from Sanofi.
• Top Trump administration health officials are questioning circumstances around measles-related deaths in Pennsylvania, with Dr. Mehmet Oz expressing uncertainty about the exact causes.
• South Carolina Senate Democratic nominee Annie Andrews critiques “Medicare for All” as outdated, advocating for pragmatic approaches in her campaign to win a statewide race.

Additional News

• FDA approves new COVID-19 vaccines for heightened-risk groups, enabling distribution to pharmacies and healthcare providers.
• Maryland reports measles outbreaks in three counties, prompting vaccination concerns.
• An initiative group sues Idaho officials over misleading abortion ballot language.

Noteworthy Reads

• Trump administration spotlighted autistic children’s challenges while reducing protective agency funding.
• RFK Jr. faces scrutiny for alleged false statements during Senate confirmation hearings.
• Hospitals pursue attempts to reverse extensive Medicaid cuts.

Stay informed with Nexstar Media Inc.’s latest political and policy news by subscribing to our Health Care newsletter. This report includes essential healthcare developments nationwide.